result guidanc in-lin debat shift
investment-driven acceler
result break new ground revenu y/i
rel in-lin estim consensu consist preview
expect result break new ground focu shift
acceler us revenu in-lin estim
grew y/i driven case volum growth revenu in-
line mse flat q/q commerci disrupt continu impact
result germani anniversari top-line guidanc modestli
rais low end y/i
remain comfort model top end despit potenti
procedur shift give higher reimburs next year gross
margin beat estim point resili
level year despit broader spine price pressur oper expens
increas y/i q/q mainli due increas sale hire
surgeon train hire new rep clinic
support specialist css latter surpass guidanc
acceler come thesi predic investment-driven
acceler particularli commerci infrastructur surgeon train
initi post-ipo reach point invest
pay dividend absolut growth rate improv
past consecut quarter stack
basi discern trend one impli
guidanc model impli comp stabil said see sever reason
optimist prospect remain comfort model
revenu y/i growth
commerci expans ahead schedul mention rep
hire track guidanc css hire target
surpass person sale forc sit ratio
rep css analysi yield revenu per rep
manag state reach css ad augment
rep product commentari suggest hire trend remain
healthi although like ramp slower pace given heavi
commerci invest model rep hire css hire
close mirror manag target ratio
payment rate rise final physician payment rate
minim invas si joint fusion mi sijf set increas
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
vs commerci rate like averag see
discuss clear upsid surpris propos
payment indic chang payment rate y/i see still
threshold survey data suggest would
impact materi step right direct contribut
acceler addit surgeon becom train activ
perform procedur manag suggest train program
progress well date remain track deliv y/i
increas activ surgeon
upcom commerci clinic catalyst
payor coverag timelin follow public ifus data
septemb see manag confid re-review
commerci payor polici come month notabl cigna
convers activ major
announc like occur januari consist publish
review timelin posit coverag decis larg
commerci payor add increment cover live ifus
associ revenu pull-through increment live
like seen patient typic undergo month
conserv therapi prior surgeri
ifus bedrock trial initi si-bon ifus bedrock long construct
deform key focu year nass see manag
reiter surgeon academ interest remain strong
convers suggest product could drive revenu
point growth long-term opportun
patient across center next two year begin
primari endpoint includ proport screw abnorm
ct scan incid si joint pain baselin chang self-
report si-joint pain note sale bedrock drive
bp growth
build block acceler remain overweight base recent
quarterli dynam commentari confer preview result
break new ground acceler look like
factor remain comfort compani abil deliv y/i
growth commentari broadli posit acceler
model sale forc set expand
becom contributor increas payment rate
drive increment surgeon interest commerci payor coverag
decis expect ifus bedrock drive bp
growth next year remain overweight price target dcf-base
price target base dcf valuat
similar spine compar price target impli
multipl base case sale premium core
spine compar given outsiz growth slight discount high
growth smid cap devic compani given acceler busi
yet proven
si-bon abl gain posit coverag decis larg commerci
payor develop addit exclus contract physician reimburs
doubl level compar open si joint fusion drive adopt
procedur growth faster anticip si-bon achiev market
penetr revenu
si-bon abl gradual expand commerci reimburs coverag
sale forc built earli physician reimburs rate rise
sale forc ramp allow broader physician awar procedur
adopt growth acceler model sale
reach
si-bon unsuccess gener addit coverag commerci
payor market adopt growth stall due lack physician interest
price pressur intensifi due increas competit achiev
market penetr
advantag penetr underserv
sacroiliac joint fusion market
differenti surgic implant ifus
implant random control studi
busi near point inflect
given momentum reimburs
landscap ii continu focu surgeon
educ iii sale forc expans
contribut meaning
addit pt penetr drive
pt growth
traction commerci payor present
opportun expand cover live
attract gross margin profil
expans patient identif
opportun deform trauma
updat coverag polici addit
expand exclus contract ifus
risk achiev price
inabl gain addit reimburs
coverag commerci payor
si joint fusion market develop
expect oper small nich
limit visibl pipelin effort
million except ep
properti plant equip net
chang allow doubt account
chang fair valu conv prefer warrant
write-off pp
amort debt discount
chang work capit
oper
invest
proce stock option exercis
financ
effect foreign exchang rate
